Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118234) titled 'Mechanism of Naringin in Improving Postmenopausal Osteoporosis by Activating BMP2-Smad1 Pathway' on Feb. 3.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Second Affiliated Hospital of Zhejiang Chinese Medical University
Condition:
Osteoporosis
Intervention:
Postmenopausal osteoporosis (PMOP) group :No
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Postmenopausal osteoporosis (PMOP) group :90;control group:86;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?pr...